Phase II trial of induction chemotherapy with carboplatin and paclitaxel plus bevacizumab in patients with stage IIIA to IV nonsquamous non-small cell lung cancer. [electronic resource]
Producer: 20190820Description: 678-685 p. digitalISSN:- 1436-2813
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab -- administration & dosage
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- mortality
- Combined Modality Therapy
- Female
- Humans
- Induction Chemotherapy
- Lung Neoplasms -- mortality
- Male
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.